SCHEMBL2809635

SCHEMBL2809635

COc1ccc(CN2CCc3n[nH]c4nc(N5CCN(Cc6ccccc6)CC5)nc2c34)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.50
CLPP Q16740 1/20 0.45
ALDH1A1 P00352 4/20 0.44
LMNA P02545 3/20 0.44
HTT P42858 2/20 0.44
MAPK1 P28482 2/20 0.44
KDM4E B2RXH2 2/20 0.44
NTSR1 P30989 1/20 0.44
GAA P10253 2/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 1/20 0.43
FAAH O00519 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2814050 1.00 SIGMAR1 (0.50) SIGMAR1CLPPALDH1A1LMNAHTT
SCHEMBL2808435 0.95 SIGMAR1 (0.48) SIGMAR1CLPPALDH1A1LMNAHTT
SCHEMBL14405858 0.93 HSD17B10 (0.43) SIGMAR1CLPPALDH1A1LMNAHTT
SCHEMBL2812014 0.87 CASP1 (0.39) ALDH1A1LMNAHTTMAPK1KDM4E
SCHEMBL2810490 0.87 MAPT (0.45) SIGMAR1ALDH1A1KDM4EGAATSHR
SCHEMBL2811863 0.87 MEN1 (0.44) ALDH1A1HTTMAPK1KDM4EGAA
SCHEMBL2810794 0.87 GAA (0.45) ALDH1A1LMNAHTTMAPK1KDM4E
SCHEMBL2811719 0.86 GAA (0.41) ALDH1A1LMNAHTTMAPK1GAA
SCHEMBL2809499 0.85 HTR6 (0.46) ALDH1A1HTTKDM4EGAA
SCHEMBL2813100 0.85 ADRA1D (0.44) MAPK1NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 SIGMAR1 4535/4885CLPP 2832/4885ALDH1A1 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.